Clinical Trial Update: Taste and Smell Dysfunction in Patients More Than Two Years After Start of Immune Checkpoint Inhibitor Therapy

View source ↗

Summary

The study update reports observations of taste and smell dysfunction occurring more than two years after initiation of immune checkpoint inhibitor therapy in pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Non-small Cell Lung Cancer
• Urogenital Cancer

Snippet

Sponsor: University Medical Center Groningen | Conditions: Melanoma, Non-small Cell Lung Cancer (NSCLC) | Status: COMPLETED